<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39430594</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Understanding long COVID: prevalence, characteristics, and risk factors in the Eastern Province of Saudi Arabia.</ArticleTitle><Pagination><StartPage>1459583</StartPage><MedlinePgn>1459583</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1459583</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1459583</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The COVID-19 pandemic has significantly raised public health concerns and efforts to limit its spread, impacting societies and health systems worldwide. As challenges persist, the emergence of Long COVID (LC) marks a turning point in understanding the pandemic's long-term effects.</AbstractText><AbstractText Label="AIM" NlmCategory="UNASSIGNED">This study aimed to determine the prevalence of LC in the Eastern Province of the Kingdom of Saudi Arabia (KSA) and explore factors contributing to its persistence.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This descriptive, cross-sectional, questionnaire-based study was carried out between December 1, 2023, and March 1, 2024, involving 1,355 patients who recovered from COVID-19. Participants were conveniently chosen and information was gathered through in-person interviews in public settings after obtaining consent.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A majority of the patients (<i>N</i>&#x2009;=&#x2009;1,355; 47.5% female; 93.8% Saudis; mean Age&#x2009;&#xb1;&#x2009;SD 33.13&#x2009;&#xb1;&#x2009;12.60&#x2009;years) had received three COVID-19 vaccine doses (89.5%). Women experienced 17.4% more LC symptoms than men (<i>p</i>&#x2009;&lt;&#x2009;0.001). The risk of having a higher symptom count increased by 42.5% 12&#x2009;months after acute COVID-19 infection compared with baseline (&lt;3&#x2009;months, <i>p</i>&#x2009;&lt;&#x2009;0.001). A higher body mass index (BMI) was associated with more symptoms (1.1% increase per unit, <i>p</i>&#x2009;=&#x2009;0.004). More acute-phase symptoms correlated with more LC symptoms (<i>p</i>&#x2009;&lt;&#x2009;0.001). Higher educational attainment reduced LC risk by 33% (<i>p</i>&#x2009;&lt;&#x2009;0.001). Finally, age and vaccination status had no effect on LC symptoms count (<i>p</i>&#x2009;&gt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Sociodemographic and clinical factors contribute differently to the chances of having LC and the count of symptoms. Awareness of such factors could provide insight into improving management, leading to better health outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Aldhawyan, BuSaad, Almaghlouth, Alnasser, Alnasser, Almansour and AlHarkan.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aldhawyan</LastName><ForeName>Adam F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>BuSaad</LastName><ForeName>Mohammed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almaghlouth</LastName><ForeName>Nawaf E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alnasser</LastName><ForeName>Abdullah H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alnasser</LastName><ForeName>Jomana A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almansour</LastName><ForeName>Abdulelah H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlHarkan</LastName><ForeName>Khalid S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">ongoing symptomatic COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID condition</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39430594</ArticleId><ArticleId IdType="pmc">PMC11486694</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1459583</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. (2020) 55:105924. doi: 10.1016/j.ijantimicag.2020.105924, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105924</ArticleId><ArticleId IdType="pmc">PMC7127800</ArticleId><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>Worldometer. Coronavirus cases . (2024). Available from: https://www.worldometers.info/coronavirus/ (Accessed April 13, 2024).</Citation></Reference><Reference><Citation>Aspinall M, Ruark L. A pandemic not Just of infection but of inequality: the Social impact of COVID-19. In: SC Schachter, WE Bolton, editors. Accelerating diagnostics in a time of crisis: the response to COVID-19 and a roadmap for future pandemics. (Cambridge, England: Cambridge University Press) (2024) p. 250&#x2013;62.</Citation></Reference><Reference><Citation>Alizadeh H, Sharifi A, Damanbagh S, Nazarnia H, Nazarnia M. Impacts of the COVID-19 pandemic on the social sphere and lessons for crisis management: a literature review. Nat Hazards. (2023) 117:2139&#x2013;64. doi: 10.1007/s11069-023-05959-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11069-023-05959-2</ArticleId><ArticleId IdType="pmc">PMC10088618</ArticleId><ArticleId IdType="pubmed">37360799</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller M, Abelsen T, S&#xf8;rensen AIV, Andersson M, Friis-Hansen L, Dilling-Hansen C, et al. . Exploring the dynamics of COVID-19 in a Greenlandic cohort: mild acute illness and moderate risk of long COVID. IJID Regions. (2024) 11:100366. doi: 10.1016/j.ijregi.2024.100366, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2024.100366</ArticleId><ArticleId IdType="pmc">PMC11081797</ArticleId><ArticleId IdType="pubmed">38736712</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Coronavirus disease (COVID-19). (2024). Available at:https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19) (Accessed August 9, 2023).</Citation></Reference><Reference><Citation>National Institutes for Health and Care Excellence . COVID-19 rapid guideline: managing the long-term effects of COVID-19. (2020). Available at:https://www.nice.org.uk/guidance/ng188 (Accessed December 18, 2020).</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention . Long COVID Basics. (2024). Available at:https://www.cdc.gov/covid/long-term-effects/index.html (Accessed July 11, 2024).</Citation></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. (2022) 54:1473&#x2013;87. doi: 10.1080/07853890.2022.2076901, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Gu X, Li H, Zhang H, Xu J. Mechanisms of long COVID: an updated review. Chin Med J Pulm Crit Care Med. (2023) 1:231&#x2013;40. doi: 10.1016/j.pccm.2023.10.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pccm.2023.10.003</ArticleId><ArticleId IdType="pmc">PMC11332859</ArticleId><ArticleId IdType="pubmed">39171285</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, Lin K, Zhang H, Xue Q, Zhu K, Yuan G, et al. . A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg Microbes Infect. (2023) 12:2220578. doi: 10.1080/22221751.2023.2220578</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2220578</ArticleId><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. (2021) 75:e13746. doi: 10.1111/ijcp.13746, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics .Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. (2023). Available at:https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023 (Accessed March 30, 2023).</Citation></Reference><Reference><Citation>National Center for Health Statistics . U.S. Census Bureau, Household Pulse Survey, 2022&#x2013;2024. Long COVID. Generated interactively. (2024). Available at:https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (Accessed June 17, 2024).</Citation></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. (2022) 328:1604&#x2013;15. doi: 10.1001/jama.2022.18931, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. (2022) 226:1593&#x2013;607. doi: 10.1093/infdis/jiac136, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud N, Radwan N, Alkattan A, Hassanien M, Elkajam E, Alqahtani S, et al. . Post-COVID-19 syndrome: nature of symptoms and associated factors. J Public Health. (2024) 32:207&#x2013;12. doi: 10.1007/s10389-022-01802-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10389-022-01802-3</ArticleId><ArticleId IdType="pmc">PMC9809515</ArticleId><ArticleId IdType="pubmed">36619479</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi SA, Alfares MA, Alsulami RA, Alghamdi AF, Almalawi AM, Alghamdi MS, et al. . Post-COVID-19 syndrome: incidence, risk factor, and the most common persisting symptoms. Cureus. (2022) 14:e32058. doi: 10.7759/cureus.32058, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.32058</ArticleId><ArticleId IdType="pmc">PMC9802640</ArticleId><ArticleId IdType="pubmed">36600841</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xed;&#x161;ka D, Liptakov&#xe1; E, Babi&#x10d;ov&#xe1; A, Batalik L, Ba&#x148;&#xe1;rov&#xe1; PS, Dobrodenkov&#xe1; S. What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health. (2022) 10:975992. doi: 10.3389/fpubh.2022.975992, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.975992</ArticleId><ArticleId IdType="pmc">PMC9667067</ArticleId><ArticleId IdType="pubmed">36408018</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019; Mahony L, Buwalda T, Blair M, Forde B, Lunjani N, Ambikan A, et al. . Impact of long COVID on health and quality of life. HRB Open Res. (2022) 5:31. doi: 10.12688/hrbopenres.13516.1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/hrbopenres.13516.1</ArticleId><ArticleId IdType="pmc">PMC9440374</ArticleId><ArticleId IdType="pubmed">36101871</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics . Self-reported long COVID after infection with the Omicron variant in the UK (2022). Available at:https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/18july2022 (Accessed July 18, 2022).</Citation></Reference><Reference><Citation>AlRadini FA, Alamri F, Aljahany MS, Almuzaini Y, Alsofayan Y, Khan A, et al. . Post-acute COVID-19 condition in Saudi Arabia: a national representative study. J Infect Public Health. (2022) 15:526&#x2013;32. doi: 10.1016/j.jiph.2022.03.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.03.013</ArticleId><ArticleId IdType="pmc">PMC8949843</ArticleId><ArticleId IdType="pubmed">35429791</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodeir MM, Shabana HA, Rasheed Z, Alkhamiss AS, Khodeir M, Alkhowailed MS, et al. . COVID-19: post-recovery long-term symptoms among patients in Saudi Arabia. PLoS One. (2021) 16:e0260259. doi: 10.1371/journal.pone.0260259, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260259</ArticleId><ArticleId IdType="pmc">PMC8654233</ArticleId><ArticleId IdType="pubmed">34879074</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. . Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. (2022) 28:657&#x2013;66. doi: 10.1016/j.cmi.2022.01.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, Tsuzuki S, Maruki T, Terada M, Miyazato Y, Kutsuna S, et al. . Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study. Public Health. (2023) 216:39&#x2013;44. doi: 10.1016/j.puhe.2023.01.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2023.01.008</ArticleId><ArticleId IdType="pubmed">36791649</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. (2021) 27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. . Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med. (2022) 11:413. doi: 10.3390/jcm11020413, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabnam S, Razieh C, Dambha-Miller H, Yates T, Gillies C, Chudasama YV, et al. . Socioeconomic inequalities of long COVID: a retrospective population-based cohort study in the United Kingdom. J R Soc Med. (2023) 116:263&#x2013;73. doi: 10.1177/01410768231168377, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231168377</ArticleId><ArticleId IdType="pmc">PMC10469969</ArticleId><ArticleId IdType="pubmed">37164035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. . Risk factors associated with post&#x2212;COVID-19 condition. JAMA Intern Med. (2023) 183:566&#x2013;80. doi: 10.1001/jamainternmed.2023.0750, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Zhang C, Bao Z. Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty. Emerg Microbes Infect. (2023) 12:2251589. doi: 10.1080/22221751.2023.2251589</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2251589</ArticleId><ArticleId IdType="pmc">PMC10469413</ArticleId><ArticleId IdType="pubmed">37606034</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambra C. Placing intersectional inequalities in health. Health Place. (2022) 75:102761. doi: 10.1016/j.healthplace.2022.102761, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthplace.2022.102761</ArticleId><ArticleId IdType="pubmed">35397319</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos VS, Siqueira TS, Atienzar AIC, Santos MAR, Vieira SCF, Lopes ASA, et al. . Spatial clusters, social determinants of health and risk of COVID-19 mortality in Brazilian children and adolescents: a nationwide population-based ecological study. Lancet Reg Health Am. (2022) 13:100311. doi: 10.1016/j.lana.2022.100311, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100311</ArticleId><ArticleId IdType="pmc">PMC9242540</ArticleId><ArticleId IdType="pubmed">35789692</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanijahani A, Iezadi S, Gholipour K, Azami-Aghdash S, Naghibi D. A systematic review of racial/ethnic and socioeconomic disparities in COVID-19. Int J Equity Health. (2021) 20:248. doi: 10.1186/s12939-021-01582-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-021-01582-4</ArticleId><ArticleId IdType="pmc">PMC8611382</ArticleId><ArticleId IdType="pubmed">34819081</ArticleId></ArticleIdList></Reference><Reference><Citation>Tancredi S, Cullati S, Chiolero A. Estimating the magnitude of surveillance bias in COVID-19. Eur J Pub Health. (2022) 32:ckac130.096. doi: 10.1093/eurpub/ckac130.096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckac130.096</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu L, Tebe C, Loste C, Santos JR, Llad&#xf3;s G, L&#xf3;pez C, et al. . Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. Lancet Reg Health Eur. (2023) 33:100724. doi: 10.1016/j.lanepe.2023.100724, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100724</ArticleId><ArticleId IdType="pmc">PMC10636281</ArticleId><ArticleId IdType="pubmed">37954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. (2022) 13:1812. doi: 10.1038/s41467-022-29513-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva KM, Freitas DCA, Medeiros SS, Miranda LVA, Carmo JBM, Silva RG, et al. . Prevalence and predictors of COVID-19 long-term symptoms: a cohort study from the Amazon Basin. Am J Trop Med Hyg. (2023) 109:466&#x2013;70. doi: 10.4269/ajtmh.22-0362, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.22-0362</ArticleId><ArticleId IdType="pmc">PMC10397456</ArticleId><ArticleId IdType="pubmed">37364863</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. (2022) 13:1957. doi: 10.1038/s41467-022-29521-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>